Connection

Perry Halushka to Thromboxane A2

Back to Details
This is a "connection" page, showing publications Perry Halushka has written about Thromboxane A2.
Perry Halushka
Connection Strength
3.017
Thromboxane A2
  1. Thromboxane A2 receptors. J Lipid Mediat Cell Signal. 1995 Oct; 12(2-3):361-78.
    View in: PubMed
    Score: 0.125
  2. Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs. Eur J Clin Invest. 1994 Feb; 24 Suppl 1:50-2.
    View in: PubMed
    Score: 0.111
  3. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1992 Aug; 262(2):632-7.
    View in: PubMed
    Score: 0.100
  4. Testosterone increases thromboxane A2 receptors in cultured rat aortic smooth muscle cells. Circ Res. 1991 Sep; 69(3):638-43.
    View in: PubMed
    Score: 0.094
  5. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets. J Biol Chem. 1991 Jul 25; 266(21):13752-8.
    View in: PubMed
    Score: 0.093
  6. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. Am J Med Sci. 2011 Feb; 341(2):101-5.
    View in: PubMed
    Score: 0.090
  7. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP. Adv Prostaglandin Thromboxane Leukot Res. 1991; 21A:331-7.
    View in: PubMed
    Score: 0.090
  8. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors. Biochem Pharmacol. 1990 Oct 01; 40(7):1457-61.
    View in: PubMed
    Score: 0.088
  9. Characterization of thromboxane A2/prostaglandin H2 receptors in human vascular smooth muscle cells. Life Sci. 1990; 46(24):1765-72.
    View in: PubMed
    Score: 0.084
  10. Radioligand binding assays for thromboxane A2/prostaglandin H2 receptors. Methods Enzymol. 1990; 187:397-405.
    View in: PubMed
    Score: 0.084
  11. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 receptor. Biochim Biophys Acta. 1989 Jul 11; 1012(2):184-90.
    View in: PubMed
    Score: 0.081
  12. Photoaffinity labelling and isoelectric focusing of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor. Adv Prostaglandin Thromboxane Leukot Res. 1989; 19:168-71.
    View in: PubMed
    Score: 0.078
  13. Pharmacology of thromboxane A2 receptor antagonists. Z Kardiol. 1989; 78 Suppl 3:42-7.
    View in: PubMed
    Score: 0.078
  14. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets. Biochem Biophys Res Commun. 1988 Dec 15; 157(2):733-9.
    View in: PubMed
    Score: 0.078
  15. Different pharmacologic activities for 13-azapinane thromboxane A2 analogs in platelets and blood vessels. Eur J Pharmacol. 1988 Apr 13; 148(3):309-15.
    View in: PubMed
    Score: 0.074
  16. Subcellular localization of a thromboxane A2/prostaglandin H2 receptor antagonist binding site in human platelets. Biochem Pharmacol. 1988 Feb 15; 37(4):647-54.
    View in: PubMed
    Score: 0.073
  17. Binding of thromboxane A2/prostaglandin H2 agonists to human platelets. Br J Pharmacol. 1987 May; 91(1):223-7.
    View in: PubMed
    Score: 0.070
  18. Thromboxane A2 in health and disease. Fed Proc. 1987 Jan; 46(1):131-2.
    View in: PubMed
    Score: 0.068
  19. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to guinea-pig platelets. Eur J Pharmacol. 1986 Nov 12; 131(1):49-54.
    View in: PubMed
    Score: 0.067
  20. Photoaffinity labelling of a thromboxane A2/prostaglandin H2 antagonist binding site in human platelets. Biochem Biophys Res Commun. 1986 Oct 15; 140(1):128-33.
    View in: PubMed
    Score: 0.067
  21. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. J Pharmacol Exp Ther. 1985 Dec; 235(3):729-34.
    View in: PubMed
    Score: 0.063
  22. Hydrodynamic properties of a thromboxane A2/prostaglandin H2 antagonist binding site solubilized from human platelets. Biochem Biophys Res Commun. 1985 Nov 15; 132(3):961-8.
    View in: PubMed
    Score: 0.063
  23. Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets. Proc Natl Acad Sci U S A. 1985 Nov; 82(21):7434-8.
    View in: PubMed
    Score: 0.063
  24. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets. Mol Pharmacol. 1985 Aug; 28(2):163-9.
    View in: PubMed
    Score: 0.062
  25. Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins. Eur J Pharmacol. 1985 Apr 23; 111(1):125-8.
    View in: PubMed
    Score: 0.060
  26. Thromboxane and prostacyclin in disease: a review. Q J Med. 1983; 52(208):461-70.
    View in: PubMed
    Score: 0.052
  27. Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2? Circulation. 2002 Apr 09; 105(14):1620-2.
    View in: PubMed
    Score: 0.049
  28. Thromboxane A2 and prostacyclin production by lipopolysaccharide-stimulated peritoneal macrophages. J Reticuloendothel Soc. 1981 Nov; 30(5):445-50.
    View in: PubMed
    Score: 0.048
  29. Implications for thromboxane A2 in the pathogenesis of endotoxic shock. Adv Shock Res. 1981; 6:83-91.
    View in: PubMed
    Score: 0.045
  30. Sensitization of essential fatty acid-deficient rats to endotoxin by arachidonate pretreatment: role of thromboxane A2. Circ Shock. 1981; 8(1):69-76.
    View in: PubMed
    Score: 0.045
  31. Thromboxane A(2) receptors: where have you gone? Prostaglandins Other Lipid Mediat. 2000 Mar; 60(4-6):175-89.
    View in: PubMed
    Score: 0.042
  32. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J Clin Invest. 1980 Jan; 65(1):227-30.
    View in: PubMed
    Score: 0.042
  33. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor. Proc Natl Acad Sci U S A. 1979 Aug; 76(8):4097-101.
    View in: PubMed
    Score: 0.041
  34. Cloning and characterization of an endogenous COS-7 cell thromboxane A2 receptor. Biochim Biophys Acta. 1998 May 27; 1403(1):109-14.
    View in: PubMed
    Score: 0.037
  35. Suppressed thromboxane production in endotoxin-desensitized THP-1 cells is not a result of decreased prostaglandin H synthase activity. Shock. 1998 May; 9(5):359-63.
    View in: PubMed
    Score: 0.037
  36. Stimulation of rat mesangial cell thromboxane A2 receptors inhibits particulate but not soluble guanylyl cyclase. Am J Physiol. 1996 Jan; 270(1 Pt 2):F31-8.
    View in: PubMed
    Score: 0.032
  37. Decrease in vascular TxA2 receptors in a subgroup of rabbits unresponsive to a TxA2 mimetic. Am J Physiol. 1994 Jun; 266(6 Pt 2):H2320-6.
    View in: PubMed
    Score: 0.028
  38. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors. Biochim Biophys Acta. 1994 Mar 10; 1221(1):83-8.
    View in: PubMed
    Score: 0.028
  39. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells. Am J Physiol. 1993 Dec; 265(6 Pt 1):E928-34.
    View in: PubMed
    Score: 0.027
  40. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with pregnancy induced hypertension. Thromb Res. 1993 May 01; 70(3):205-10.
    View in: PubMed
    Score: 0.026
  41. Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition. Am Rev Respir Dis. 1991 Nov; 144(5):1095-101.
    View in: PubMed
    Score: 0.024
  42. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat. Biochem Pharmacol. 1991 Jul 15; 42(3):537-44.
    View in: PubMed
    Score: 0.023
  43. Endotoxin tolerance differentially alters hemodynamic responses to a thromboxane A2 mimetic and phenylephrine. J Cardiovasc Pharmacol. 1991 Jan; 17(1):20-6.
    View in: PubMed
    Score: 0.022
  44. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction. Circulation. 1990 Jan; 81(1):212-8.
    View in: PubMed
    Score: 0.021
  45. Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1989 Sep; 250(3):923-7.
    View in: PubMed
    Score: 0.020
  46. Difluorothromboxane A2 and stereoisomers: stable derivatives of thromboxane A2 with differential effects on platelets and blood vessels. Proc Natl Acad Sci U S A. 1989 Jul; 86(14):5600-4.
    View in: PubMed
    Score: 0.020
  47. Thromboxane and prostacyclin receptors. Prog Clin Biol Res. 1989; 301:21-8.
    View in: PubMed
    Score: 0.020
  48. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor. Prog Clin Biol Res. 1989; 301:303-7.
    View in: PubMed
    Score: 0.020
  49. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619. J Pharmacol Exp Ther. 1988 Dec; 247(3):1133-8.
    View in: PubMed
    Score: 0.019
  50. Polymyxin B increases TXA2/PGH2 agonist and antagonist affinities in human platelet membranes. Eicosanoids. 1988; 1(1):41-4.
    View in: PubMed
    Score: 0.018
  51. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant. Biochem Pharmacol. 1987 Jun 15; 36(12):1913-7.
    View in: PubMed
    Score: 0.018
  52. Cultured human vascular smooth muscle cells with functional thromboxane A2 receptors: measurement of U46619-induced 45calcium efflux. Circ Res. 1987 Jun; 60(6):952-6.
    View in: PubMed
    Score: 0.017
  53. Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors. Fed Proc. 1987 Jan; 46(1):149-53.
    View in: PubMed
    Score: 0.017
  54. Thromboxane, prostacyclin, and leukotrienes in cerebral ischemia. Neurology. 1986 Apr; 36(4):466-70.
    View in: PubMed
    Score: 0.016
  55. Identification of a putative thromboxane A2/prostaglandin H2 receptor in human platelet membranes. J Biol Chem. 1986 Mar 05; 261(7):3025-9.
    View in: PubMed
    Score: 0.016
  56. Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock. Intensive Care Med. 1986; 12(3):116-26.
    View in: PubMed
    Score: 0.016
  57. Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle. Circulation. 1985 Dec; 72(6):1202-7.
    View in: PubMed
    Score: 0.016
  58. Insulin and arachidonic acid metabolism in diabetes mellitus. Metabolism. 1985 Dec; 34(12 Suppl 1):32-6.
    View in: PubMed
    Score: 0.016
  59. Alteration of thromboxane and prostacyclin levels in experimental spinal cord injury. Neurology. 1985 Jul; 35(7):1003-9.
    View in: PubMed
    Score: 0.015
  60. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. J Pharmacol Exp Ther. 1985 May; 233(2):418-24.
    View in: PubMed
    Score: 0.015
  61. Gentamicin and indomethacin in the treatment of septic shock: effects on prostacyclin and thromboxane A2 production. J Pharmacol Exp Ther. 1983 Apr; 225(1):94-101.
    View in: PubMed
    Score: 0.013
  62. Thromboxane and prostacyclin production during septic shock. Adv Shock Res. 1982; 7:133-45.
    View in: PubMed
    Score: 0.012
  63. Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med. 1981 Jan; 97(1):87-96.
    View in: PubMed
    Score: 0.011
  64. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1998 Apr 28; 95(9):4888-93.
    View in: PubMed
    Score: 0.009
  65. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. J Pharmacol Exp Ther. 1994 Sep; 270(3):1192-6.
    View in: PubMed
    Score: 0.007
  66. Increased thromboxane level in experimental spinal cord injury. J Neurol Sci. 1986 Jul; 74(2-3):289-96.
    View in: PubMed
    Score: 0.004
  67. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes. 1985 Nov; 34(11):1127-33.
    View in: PubMed
    Score: 0.004
  68. Plasma thromboxane concentrations are raised in patients dying with septic shock. Lancet. 1982 Jul 24; 2(8291):174-5.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.